AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

C-RAD

Director's Dealing Oct 10, 2016

3148_rns_2016-10-10_40a169c2-8e41-4c42-b14d-b503ddb08073.pdf

Director's Dealing

Open in Viewer

Opens in native device viewer

Press release 2016-10-10

C-RAD has been informed that Lars Nyberg bought one million B shares

C-RAD has been informed that the Chairman of the Board, Lars Nyberg, bought one million C-RAD B shares from the three biggest owners, Per Hamberg, Olle Stenfors and Lars Kling on October 7, 2016. After the transaction he owns 1.250.000 B shares in the company. This transaction is beyond his interest to buy another 600.000 B shares in connection with the Board's decision regarding a private placement of 2 million shares. However, that requires an approval of the majority of the shareholder meeting as communicated earlier.

About C-RAD

C-RAD develops innovative solutions for use in advanced radiation therapy. The C-RAD group offers products and solutions for patient positioning, tumor localization and radiation treatment systems. All product development is conducted in three fully owned subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB, all of which are located in Uppsala, Sweden. Employees currently number 45. C-RAD has established three companies for direct sales: C-RAD Inc. in the US, C-RAD GmbH in Germany and C-RAD WOFE in China. Cyrpa International SPRL, a Franco-Belgian laser company, is a wholly owned subsidiary whose operations are integrated. C-RAD AB is listed on NASDAQ Stockholm. For more information on C-RAD, please visit www.c-rad.com

For further information:

Tim Thurn, CEO C-RAD AB, Phone +46-18-666930, Email [email protected]

The above information is price-sensitive and must therefore be disclosed under the Securities Market Act (2007:528).

Talk to a Data Expert

Have a question? We'll get back to you promptly.